AGC
PEARW

Angelo Gordon & Co’s Pear Therapeutics, Inc. Warrant PEARW Stock Holding History

Angelo Gordon & Co’s Portfolio PEARW Stock Details PEARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-33,332
Closed -$8.5K – 119
2023
Q1 		$8.5K Buy
+33,332
New +$3.21K ﹤0.01% 114

Other funds holding PEARW

AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Angelo Gordon & Co's PEARW Position: Q1 2023 in Review

Angelo Gordon & Co sold out of Pear Therapeutics, Inc. Warrant (PEARW) in Q1 2023, closing a stake of 33,332 shares — an estimated $3.21K sold.

Angelo Gordon & Co first reported a position in PEARW in Q2 2021 and held it in 7 quarters. The position peaked at $331K in Q3 2021. 33 funds tracked by Wall St. Rank hold PEARW as of Q1 2023.

  • Angelo Gordon & Co reported no remaining Pear Therapeutics, Inc. Warrant position as of Q1 2023 after selling out during the quarter.
  • Angelo Gordon & Co sold 33,332 Pear Therapeutics, Inc. Warrant shares in Q1 2023, an estimated $3.21K.
  • Angelo Gordon & Co first reported a position in Pear Therapeutics, Inc. Warrant in Q2 2021 and held it in 7 quarters.
  • Angelo Gordon & Co's Pear Therapeutics, Inc. Warrant position peaked at $331K in Q3 2021.
  • 33 funds tracked by Wall St. Rank held Pear Therapeutics, Inc. Warrant as of Q1 2023.

Based on Angelo Gordon & Co's 13F filing for Q1 2023, filed 15 May 2023.